Definition and epidemiology
Osteosarcoma is a malignant primary bone tumor characterized by malignant mesenchymal cells producing immature, woven osteoid or bone matrix. It is the most common primary bone malignancy in children and adolescents, though it remains rare overall.
- Bimodal age distribution: first peak in the second decade of life (10-20 years), coinciding with periods of rapid bone growth; second, smaller peak in adults over 60-65 years
- Slight male predominance
- Most common sites are the metaphysis of long bones with high growth rates: distal femur, proximal tibia, and proximal humerus
- Accounts for a minority of all cancers but is the leading cause of cancer-related bone tumors in youth
- Bimodal age distribution: adolescents and older adults with Paget disease
- Classic location: metaphysis of distal femur or proximal tibia
- Codman triangle and sunburst pattern on x-ray are classic but not pathognomonic
- Associated with RB1 (retinoblastoma) and TP53 (Li-Fraumeni) mutations
- Lungs are the most common site of hematogenous metastasis
- MAP regimen (methotrexate, doxorubicin, cisplatin) is standard chemotherapy
- Limb-salvage surgery preferred over amputation when margins allow
- Degree of tumor necrosis after neoadjuvant chemotherapy predicts prognosis
Etiology and risk factors
Most cases are sporadic, but several well-established associations increase risk.
- Rapid bone growth: adolescent growth spurt, taller-than-average stature
- Paget disease of bone in older adults (secondary osteosarcoma)
- Prior radiation therapy to bone (radiation-induced sarcoma, typically years after exposure)
- Hereditary retinoblastoma (RB1 gene mutation) markedly increases risk
- Li-Fraumeni syndrome (TP53 germline mutation)
- Rothmund-Thomson syndrome and other rare genetic syndromes
- Chronic bone infarcts, Ollier disease, and fibrous dysplasia are less common associations
Pathophysiology
Osteosarcoma arises from malignant transformation of osteoblastic precursor cells, leading to production of disorganized, immature osteoid or woven bone matrix rather than normal lamellar bone. Loss of tumor suppressor function (RB1, TP53) is central to pathogenesis, consistent with the syndromic associations above.
The tumor typically originates in the metaphysis, where growth plate activity is highest, and grows aggressively, breaking through cortical bone and lifting the periosteum. This periosteal elevation produces the characteristic imaging findings (Codman triangle, sunburst pattern) and corresponds histologically to malignant osteoid deposition with marked cellular atypia and mitotic activity.
Histologic subtypes include conventional (osteoblastic, chondroblastic, fibroblastic), telangiectatic, small cell, and parosteal/periosteal (lower-grade surface variants). Hematogenous spread, especially to the lungs, is the dominant pattern of metastasis; lymphatic spread is uncommon.
Clinical features
- Localized bone pain, often worse at night and initially attributed to growing pains or minor trauma
- Progressive, painful swelling or palpable mass near the knee (distal femur or proximal tibia most common) or proximal humerus
- Decreased range of motion of the adjacent joint
- Pathologic fracture at the tumor site in a minority of patients
- Systemic symptoms (fever, weight loss) are uncommon at presentation and should raise suspicion for an alternative diagnosis such as Ewing sarcoma or osteomyelitis
- Symptom duration before diagnosis is often several weeks to months due to nonspecific early presentation
Diagnosis
Imaging
- Plain radiograph is the initial study: shows a mixed lytic-sclerotic lesion in the metaphysis with cortical destruction
- Classic findings: 'sunburst' pattern (radiating spicules of new bone) and Codman triangle (periosteal elevation at tumor margins)
- MRI of the entire bone is essential for local staging: defines intraosseous extent, soft tissue involvement, neurovascular proximity, and skip lesions
- CT chest and bone scan (or PET-CT) for metastatic workup, since lungs and other bones are the main sites of spread
Confirmation
- Biopsy (core needle or open) is required for definitive diagnosis and must be performed by or coordinated with the treating orthopedic oncology center, since biopsy tract placement affects future surgical planning
- Histology shows malignant spindle cells producing osteoid matrix
- Serum alkaline phosphatase and lactate dehydrogenase are often elevated and have prognostic value, but are nonspecific
Staging
- Based on tumor size, grade, and presence of metastasis (commonly using the Enneking or AJCC system)
- Lungs are the most common site of metastasis at diagnosis, present in a minority of patients
Differential diagnosis
| Condition | Distinguishing feature |
|---|---|
| Ewing sarcoma | Diaphyseal location, onion-skin periosteal reaction, younger age, 'small round blue cells' on histology |
| Osteomyelitis | Fever, elevated inflammatory markers, sequestrum/involucrum on imaging |
| Osteochondroma | Benign, pedunculated bony outgrowth with cortical/medullary continuity |
| Giant cell tumor of bone | Epiphyseal location in skeletally mature patients, soap-bubble lytic lesion |
| Chondrosarcoma | Older adults, popcorn/ring-and-arc calcifications, central/axial skeleton |
| Aneurysmal bone cyst | Expansile lytic lesion, fluid-fluid levels on MRI |
| Stress fracture | History of repetitive activity, linear fracture line without soft tissue mass |
Management
Management requires a multidisciplinary team (orthopedic oncology, medical/pediatric oncology, radiation oncology, and pathology) at a specialized center, following current NCCN and European sarcoma group consensus.
Chemotherapy
- Neoadjuvant (preoperative) multiagent chemotherapy is standard for high-grade conventional osteosarcoma, typically combining methotrexate (high-dose), doxorubicin, and cisplatin (MAP regimen)
- Adjuvant (postoperative) chemotherapy continues after surgical resection
- Response to neoadjuvant chemotherapy (percentage tumor necrosis on resected specimen) is a major prognostic factor and may guide adjuvant regimen intensity
Surgery
- Limb-sparing (limb-salvage) resection with wide margins is preferred over amputation whenever feasible, followed by endoprosthetic or biologic reconstruction
- Amputation is reserved for cases where clear margins or functional limb salvage are not achievable
- Pulmonary metastasectomy is considered for resectable lung metastases, as surgical removal improves outcomes compared with chemotherapy alone
Other
- Radiotherapy has a limited role, since osteosarcoma is relatively radioresistant; it is reserved for unresectable disease or positive margins
- Low-grade surface variants (parosteal osteosarcoma) may be treated with surgery alone, without chemotherapy
- Targeted/immunotherapy approaches remain investigational outside clinical trials
Complications and prognosis
- Pulmonary metastasis is the most common and most important determinant of outcome
- Local recurrence can occur despite adequate resection, particularly with poor chemotherapy response
- Pathologic fracture, limb-length discrepancy, and prosthesis-related complications (infection, loosening) are long-term concerns after limb-salvage surgery
- Chemotherapy toxicities include cardiotoxicity (doxorubicin), nephrotoxicity and ototoxicity (cisplatin), and myelosuppression
- Five-year survival for localized, resectable disease is substantially higher (majority of patients survive long-term) compared with metastatic disease at diagnosis, where survival is markedly lower
- Good histologic response to neoadjuvant chemotherapy (high percentage tumor necrosis) is associated with improved survival
MAP = Methotrexate, Adriamycin (doxorubicin), Platinum (cisplatin) — the chemo backbone of osteosarcoma treatment
Practice questions
1. A 14-year-old boy presents with 2 months of progressive right knee pain and swelling, worse at night. X-ray shows a destructive lesion in the distal femoral metaphysis with a mixed lytic-sclerotic pattern, cortical breakthrough, and radiating spicules of bone extending into the soft tissue. Which of the following is the most appropriate next step?
2. A 68-year-old man with a long history of Paget disease of bone develops new, severe pain in his right femur. Imaging reveals an aggressive destructive lesion with cortical disruption at a site of known Paget involvement. Biopsy confirms osteosarcoma. Which feature of this presentation is most consistent with the epidemiology of osteosarcoma?
3. A 15-year-old girl undergoes neoadjuvant chemotherapy followed by limb-salvage resection for a high-grade osteosarcoma of the proximal tibia. Pathology of the resected specimen shows greater than 90% tumor necrosis. Which statement best reflects the significance of this finding?
Frequently asked questions
What causes osteosarcoma?
Most cases are sporadic and arise during periods of rapid bone growth, but genetic factors matter: hereditary retinoblastoma (RB1 mutation), Li-Fraumeni syndrome (TP53 mutation), prior radiation to bone, and Paget disease in older adults are established risk factors. There is no single external cause identified for most sporadic cases.
What are the first symptoms of osteosarcoma?
The earliest symptom is usually localized, dull bone pain near a joint such as the knee, often worse at night and initially mistaken for growing pains or minor injury. A palpable, enlarging mass and reduced range of motion typically follow within weeks to months as the tumor grows.
How is osteosarcoma diagnosed?
Diagnosis starts with a plain x-ray showing a destructive metaphyseal lesion with periosteal reaction, followed by MRI to define local extent. CT chest and bone scan or PET-CT assess for metastasis. A biopsy, ideally performed at the treating cancer center, confirms the diagnosis histologically.
Is osteosarcoma curable?
Yes, localized osteosarcoma is potentially curable, with the majority of patients achieving long-term survival after combined chemotherapy and surgical resection. Outcomes are significantly worse when metastatic disease, most often to the lungs, is present at diagnosis or develops later.
Osteosarcoma vs Ewing sarcoma — what is the difference?
Osteosarcoma typically affects the metaphysis of long bones in adolescents and shows osteoid-producing spindle cells with a sunburst pattern on imaging. Ewing sarcoma more often arises in the diaphysis, affects a slightly younger age group, shows an onion-skin periosteal reaction, and consists of small round blue cells without matrix production.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: C40
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.